Posts in tag

heart disease


Debbie Rigby rounds up the latest in research news Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections A large population-based cohort study using US-based databases has shown …

As roles for community pharmacists continue to expand, helping patients to maintain their cardiovascular health is more important than ever, writes Sheshtyn Paola Back in mid-2005, pharmacy researchers reached out …

Drug-induced deaths are at their highest rate since the late ’90s, new data from the ABS shows – but the profile of such deaths is very different “There were 1,808 …

Artificial intelligence (AI) and computer algorithms are being used to predict lifespan and detect malignant tumours Researchers at the University of Adelaide have recently used artificial intelligence to predict five-year …

Recent findings that NSAIDs increase risk of heart attack have minimal implications, argues ASMI A recent BMJ study found that all non-steroidal anti-inflammatory drugs (NSAIDs), including over-the-counter medicines such as …

With men more likely than women to have their cardiovascular disease risk factors measured by their GP, can pharmacists help bridge the divide? Research from The George Institute for Global …

Women from low socioeconomic backgrounds are 25% more likely to suffer a heart attack than disadvantaged men, a major new study has found Researchers from The George Institute for Global …

Australia is facing a resurgence of cardiovascular disease – the country’s number one killer A deadly combination of obesity and type 2 diabetes, in addition to rising rates of atrial …

World-first results: Researchers have found a drug combination that reduces coronary atherosclerosis more effectively than statins alone In an Australian-led multicenter, double-blind, placebo-controlled, randomised clinical trial, researchers have discovered that a …

Debbie Rigby presents the latest research news relevant to pharmacy Heart Failure Outcomes With Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk In patients with type 2 …

With a more advanced scope of practice, pharmacists can achieve positive results for patients A Canadian trial has shown intensive pharmacist intervention may help reduce cardiovascular risk in patients. Community pharmacists …

The National Heart Foundation of Australia says the fact that heart disease remains the country’s single leading killer following the release of the 2013 Cause of Death Data from the …